🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Saba Capital and Boaz Weinstein sell $700,625 in BlackRock Capital shares

Published 10/24/2024, 11:09 AM
BCAT
-

NEW YORK—Saba Capital Management, L.P. and Boaz Weinstein, both significant shareholders of BlackRock (NYSE:BLK) Capital Allocation Term Trust (NYSE:BCAT), have sold shares worth approximately $700,625, according to a recent filing with the Securities and Exchange Commission.

The transactions occurred over two days. On October 22, 19,442 shares were sold at a price of $16.20 per share. The following day, October 23, saw the sale of 23,895 shares at $16.14 per share. These sales leave Saba Capital and Weinstein with a remaining holding of 14,845,533 shares in the trust.

The sale of shares was reported as indirect ownership, indicating the shares were likely held through an entity rather than directly by Saba Capital or Weinstein. The transactions reflect a minor reduction in their overall holdings in the BlackRock fund, which is known for its diversified investment strategy.

InvestingPro Insights

While Saba Capital and Boaz Weinstein have reduced their stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT), the trust continues to offer attractive features for income-focused investors. According to InvestingPro data, BCAT boasts a remarkable dividend yield of 21.4%, with the most recent ex-dividend date on October 15, 2024. This aligns with one of the InvestingPro Tips, which notes that BCAT "pays a significant dividend to shareholders."

The trust's market capitalization stands at $1.73 billion, with a relatively low P/E ratio of 8.78, potentially indicating an undervalued position. Despite the recent share sales by major shareholders, BCAT has demonstrated strong performance, with a year-to-date total return of 22.42% and a one-year total return of 32.91%.

Another InvestingPro Tip highlights that the stock "generally trades with low price volatility," which may appeal to risk-averse investors seeking stable income. This characteristic is supported by the trust's price being at 93.89% of its 52-week high, suggesting relatively steady performance.

For investors interested in a deeper analysis, InvestingPro offers additional tips and metrics to further evaluate BCAT's investment potential. There are 2 more InvestingPro Tips available for BCAT, providing a more comprehensive view of the trust's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.